Small MSK trial: high-fiber plant-based diet delayed progression of precursor myeloma
A first-of-its-kind Memorial Sloan Kettering trial gave 20 overweight people with precursor blood disorders 12 weeks of plant-based meals with coaching. None had progressed at one year, and two with previously progressing disease improved. Researchers think increased gut butyrate may be involved; a 150-person trial (NUTRIVENTION-3) is enrolling.
